Dianthus Therapeutics, Inc. /DE/ (DNTH) insider trading

By person

33 insiders · 121 transactions

10.8×

Marino Garcia holds 10.8 times base salary in stock. $6.82M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marino Garcia last reported holding, valued at $104.39, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Garcia Marino

CEO AND PRESIDENT

—

$27.96M (12) scheduled

−$27.96M

65,292

0.1167%

$6.82M

—

Savitz Ryan

EVP, CFO & CBO

—

$14.99M (14) scheduled

−$14.99M

0.0000%

$0.00

—

Randhawa Simrat

EVP, Head of R&D

$52.80K (2)

$15.00M (11) scheduled

−$14.95M

4,000

0.0072%

$417.56K

—

Booth Bruce

Director

$10.00M (1)

$254.42K (1)

+$9.75M

1,250,000

2.23%

$130.49M

—

CARR EDWARD

CHIEF ACCOUNTING OFFICER

—

$5.59M (10) scheduled

−$5.59M

0.0000%

$0.00

—

Veness Adam M

SVP, General Counsel and Sec.

—

$4.63M (5) scheduled

−$4.63M

15,000

0.0268%

$1.57M

—

Third Rock Ventures IV, L.P. entity

10% owner

—

$3.06M (2)

−$3.06M

3,058,204

5.47%

$319.25M

+3,061%

Soteropoulos Paula

Director

—

$2.25M (3) scheduled

−$2.25M

0.0000%

$0.00

—

GARDNER JASON

See Remarks

$6.00K (1)

$1.79M (8)

−$1.79M

651,964

1.17%

$68.06M

−3.3%

Fairmount Funds Management LLC entity

Director

$1.40M (5)

—

+$1.40M

0.0000%

$0.00

—

McGeorge Anne

Director

—

$844.82K (5) scheduled

−$844.82K

0.0000%

$0.00

—

COOKE MICHAEL P.

Chief Scientific Officer

—

$654.33K (14)

−$654.33K

240,523

0.4300%

$25.11M

−16.7%

Read Simon

Director

—

$630.79K (7) scheduled

−$630.79K

0.0000%

$0.00

—

DAVIS JOHN C. JR

See Remarks

—

$508.64K (4) scheduled

−$508.64K

8,304

0.0148%

$866.85K

—

ISACSON CHRISTINA K.

Chief Business Officer

—

$316.64K (3)

−$316.64K

83,786

0.1498%

$8.75M

−16.7%

Atlas Venture Fund X, L.P. entity

10% owner

—

$254.42K (1)

−$254.42K

3,148,399

5.63%

$328.66M

+3,154%

ZDRAVESKI ZORAN

See Remarks

—

$193.45K (2)

−$193.45K

128,009

0.2289%

$13.36M

−5.5%

Scadden David

Director

$99.00K (1)

—

+$99.00K

228,175

0.4079%

$23.82M

+17.9%

Deardorf Caren

Chief Commercial Officer

—

$41.98K (1)

−$41.98K

19,762

0.0353%

$2.06M

—

Beetham Thomas W.

See Remarks

—

$41.07K (1)

−$41.07K

19,897

0.0356%

$2.08M

—

Mahoney Stephen F.

See Remarks

—

$38.60K (1)

−$38.60K

17,264

0.0309%

$1.80M

—

Olson Lisa

See Remarks

—

$38.60K (1)

−$38.60K

14,264

0.0255%

$1.49M

—

Stants Kristen

Chief People Officer

—

$38.60K (1)

−$38.60K

20,264

0.0362%

$2.12M

—

Nichols David Wayne

Chief Technical Officer

—

$38.32K (1)

−$38.32K

14,306

0.0256%

$1.49M

—

Byers Blake

Director

—

3,339,137

5.97%

$348.57M

—

GV 2016 GP, L.L.C.

10% owner

—

3,339,137

5.97%

$348.57M

—

Meng Lei

Director

—

2,717,554

4.86%

$283.69M

+123.2%

MOULDER LEON O JR

Director

—

1,436,745

2.57%

$149.98M

+13.1%

RONNEBERG AMY L

Director

—

593,611

1.06%

$61.97M

—

BONNEY MICHAEL W

Director

—

215,346

0.3850%

$22.48M

+11.3%

Daniel Thomas O

Director

—

101,926

0.1822%

$10.64M

+31.7%

Albers Jeffrey W.

Director

—

4,152

0.0074%

$433.43K

—

Borisy Alexis

Director

—

4,100

0.0073%

$428.00K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Fairmount Funds Management LLC

29 Sep 2023

Director

Buy indirect

24,670

$13.63

$336.25K

Fairmount Funds Management LLC

26 Sep 2023

Director

Buy indirect

30,000

$13.15

$394.50K

Randhawa Simrat

22 Sep 2023

Chief Medical Officer

Buy

2,000

$13.20

$26.40K

Randhawa Simrat

21 Sep 2023

Chief Medical Officer

Buy

2,000

$13.20

$26.40K

Fairmount Funds Management LLC

19 Sep 2023

Director

Buy indirect

30,000

$13.20

$396.00K

Fairmount Funds Management LLC

13 Sep 2023

Director

Buy indirect

9,367

$11.76

$110.16K

Fairmount Funds Management LLC

12 Sep 2023

Director

Buy indirect

14,887

$10.85

$161.52K

Booth Bruce

29 Jun 2020

Director

Buy indirect

1,250,000

$8.00

$10.00M

GARDNER JASON

25 Jun 2018

See Remarks

Buy

400

$15.00

$6.00K

Scadden David

25 Jun 2018

Director

Buy

6,600

$15.00

$99.00K

Show all 121 transactions →

Dianthus Therapeutics, Inc. /DE/

By person

Individual transactions

What was left out